Zydus Gets CDSCO Panel Nod to Conduct Phase IV Trial for Indacaterol-Budesonide FDC Inhalation Dr. Divya Colin20 Jun 2025 11:45 PM ISTNew Delhi: In response to the proposal presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Albuterol-budesonide combo lowered risk of a severe asthma exacerbation: NEJM Jacinthlyn Sylvia1 Jun 2025 8:30 PM ISTA new study published in The New England Journal of Medicine showed that the participants with asthma who remained uncontrolled despite therapy were...
AstraZeneca Trixeo Aerosphere approved in UK as inhaled respiratory medicine using next-generation propellant with near-zero Global Warming Potential Ruchika Sharma13 May 2025 10:30 AM ISTCambridge: AstraZeneca's Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), already licensed for the treatment of...
AstraZeneca Breztri met primary endpoints in Phase III trials in asthma Ruchika Sharma4 May 2025 10:30 AM ISTAstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that...
Early Intratracheal Budesonide Treatment Has Minimal Effect on BPD-Free Survival in Preterm Infants: PLUSS Trial Medha Baranwal19 Nov 2024 8:30 PM ISTAustralia: In extremely preterm infants treated with surfactant for respiratory distress syndrome, early administration of intratracheal budesonide...
Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA Farhat Nasim19 Nov 2024 6:19 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month period ending...
AstraZeneca gets CDSCO Panel nod to study Budesonide, Glycopyrronium and Formoterol Fumarate Dr. Divya Colin20 Oct 2024 5:45 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Include nebulization methodology, nebulizer types: CDSCO Panel Tells Glenmark pharmaceuticals on Pulmonary FDC Dr. Divya Colin14 Jun 2024 6:00 PM ISTNew Delhi: Citing to include nebulization methodology, type of nebulizer, and interface, the Subject Expert Committee (SEC) functional under the...
Budesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real world study Dr. Shravani Dali7 Jun 2024 8:30 PM ISTBudesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real-world study suggests a study published in the International...
NPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation Dr. Divya Colin2 Jun 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Department of...
Not approved as Inhalation suspension for nebulization, Conduct CT: CDSCO Panel Tells Glenmark on Pulmonary FDC Dr. Divya Colin2 April 2024 6:00 PM ISTNew Delhi: Noting that the proposed fixed-dose combination (FDC) of Glycopyrrolate plus Formoterol Fumarate Dihydrate plus Budesonide (25mcg+20mcg+500...
AstraZeneca Pharma India, Mankind Pharma collaborate to distribute asthma medicine Symbicort in India Ruchika Sharma13 March 2024 2:30 PM ISTBangalore: AstraZeneca Pharma India Limited and Mankind Pharma Limited have entered into an agreement for exclusive distribution of AstraZeneca’s...
